Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)
Clinical trial NCT00493805 · TERMINATED
Trial details
- NCT number
- NCT00493805
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-10-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.